Assume that all active pharmaceutical ingredients, excipients, ingredients, components and parts for the blood pressure drug and AED device are obtained by HealthCorp from California suppliers. Also, HealthCorp has a finished goods distribution center in Nevada to fulfill internet orders. The FD&C Act's basic purpose is to protect the public. So FDA seeks to control the adulterated products and prevent further manufacturing and commercial distribution of the adulterated drugs and devices. Assuming little or no voluntary recall cooperation from HealthCorp, FDA initiates a seizure and condemnation action to remove all drug and device products that can be located from the market. The product is immediately "seized" when the suit is started. FDA also seeks an injunction to prevent further manufacturing and commercial distribution of violative products from HealthCorp's manufacturing establishment and commercial distribution from the finished goods distribution center. Consider the following situations and state whether FDA can seize or enjoin the violative products and give reasons why. 4. Are the violative drugs seizable on HealthCorp's premises? Why? 5. Are the violative devices seizable on HealthCorp's premises? Why? 6. Are the violative drugs seizable at any of HealthCorp's local San Francisco retailers? Why? 7. Are the violative devices seizable at any of HealthCorp's local San Francisco retailers? Why? 8. Are the violative drugs seizable at HealthCorp's Nevada finished goods distribution center? Why? 9. Are the violative devices seizable at HealthCorp's Nevada finished goods distribution center? Why